April 21, 2009 – In a study in which researchers from the MD Anderson Cancer Centre Orlando, FL, and the University of Wisconsin, Madison, conducted an analysis of prostate motion during helical tomotherapy, they concluded that the impact on target dose is actually quite small (Int. J. Rad. Oncol. Biol. Phys. doi: 10.1016/j.ijrobp.2008.09.035).

The study marked the first time that helical tomotherapy has been considered in similar detail. Researchers used electromagnetic markers by Calypso Medical Technologies to track prostate motion. Three markers were implanted under ultrasound guidance in 16 patients who went on to receive IMRT. Tomotherapy treatment plans were generated retrospectively and compared with motion tracks from the markers.

Two separate scenarios were considered. The first assumed that treatment started at the beginning of the observation period. The second anticipated an estimated delay of five minutes between patient alignment and the start of treatment. The minimum dose (Dmin), maximum dose (Dmax) and dose to 95 percent of the volume (D95 percent) were calculated for the whole prostate and for the planning target volume (PTV). These values were then compared with the doses that would have been delivered had the prostate stayed still. The cumulative effect was also evaluated over the course of treatment.

The results showed that for individual fractions, target D95 percent could be reduced by as much as 20 percent. However, the effect of such sizeable dose reductions diminished quickly as treatment continued. The effect on target D95 percent was less than 1 percent by the time that five fractions had been delivered. The biggest surprise was the similarity in observed changes to D95 percent for the prostate and the PTV.

While the results only apply to whole-prostate tomotherapy, researchers will test other techniques that may be affected more by organ motion, such as dose-painting, in a follow-up study.

For more information: www.redjournal.org


Related Content

News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | Computed Tomography (CT)

Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...

Time November 13, 2024
arrow
News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
Subscribe Now